📢 Our new paper is out!
Enzyme Replacement Therapy for FABRY Disease: Possible Strategies to Improve Its Efficacy
https://t.co/6RDT10FwN1 #mdpiijms via @IJMS_MDPI
"Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease"
Our new paper is out! @ryan_vignogna@eperlste
https://t.co/tomBqcxrFD @eLife
📢 Our new paper is out!
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones https://t.co/Kzt24GQaaE #mdpiijms via @IJMS_MDPI@MDPIOpenAccess
🗣 Don’t miss the opportunity to present your #research work about #proteins at #Webpro conference!
⏳Deadline for abstract submission is tomorrow⌛️
https://t.co/23GS3yCRa6
Why does #SARS_CoV_2 hit in different ways? Host genetic factors can influence the acquisition or the course of #COVID19
https://t.co/IJkyUDYOsa
@ElsevierConnect
WebPro 4th session "#structure-function relationship: an evergreen topic in #proteins" features a Plenary Lecture of the @royalsociety Fellow Professor Tom Blundell @Cambridge_Uni.
Save the date: May 20-21 🗓️
Program, registration and abstract submission: https://t.co/23GS3yCRa6
Nonostante le difficoltà di un embargo criminale, #Cuba ha una sanità tra le migliori al mondo. L'equipe arrivata in #Italia è un gesto di internazionalismo e solidarietà tra popoli dalla forte valenza pratica e simbolica, nel solco dell'insegnamento di #FidelCastro#COVIDー19
This 👌🏽 I wish I’d read this as a 1st year PhD student. I’ve made countless “stupid mistakes” and am always left feeling a bit of #impostersyndrome but as this article says, I’ve always leant a lot from my mistakes and they’ve made me become a better researcher. #AcademicTwitter
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones
#cdg#RareDisease@MDPIOpenAccess
https://t.co/SYtekgjIY9
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
#modifiers#bioinformatics#cdg#raredisease
https://t.co/OA4uMNmK2c